The response rate to 19-28z CAR-T therapy was 100% for those with pretreatment MRD who received preconditioning chemotherapy with high-dose cyclophosphamide.
A new study aims to address the conundrum of coagulation risk in patients hospitalized for hematologic malignancies.
Patients with blood cancers were more likely to enroll in hospice earlier if they included a hematologic oncologist in their first discussion about their goals of care.
Researchers found a low incidence of thrombotic events in patients receiving ibrutinib, though some patients still experienced bleeding.
Results of the PRISM-P trial compared the benefits parents of children with cancer derived from resilience training in a 1-on-1 setting vs group setting vs usual psychosocial care alone.
A retrospective study evaluated the incidence of respiratory adverse events in children and adolescents with AML who received induction chemotherapy.
Presence of a complex karyotype did not affect progression-free or overall survival.
Using validated assessment tools, researchers compared patients’ perceptions of HRQOL while undergoing treatment for CML with 1 of 2 TKIs.
A report on oncofertility identifies the optimal multidisciplinary team for assuring that young patients with cancer can preserve their fertility and the options available to them for family building.
Certain malignancies, younger age at diagnosis, and multiple affected relatives were all associated with increased familial relative risks.
